Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.01%40.63B | 12.50%159.65B | 19.00%38.69B | 7.22%141.92B | 8.64%38.05B | 1.15%37.2B | 15.14%34.16B | 5.21%32.51B | 20.58%132.36B | 18.05%35.02B |
| Cost of revenue | 1.92%28.83B | 11.60%115.63B | 18.76%28.29B | 8.35%103.61B | 11.43%28.6B | 2.52%26.51B | 13.33%24.68B | 6.70%23.82B | 23.15%95.62B | 20.48%25.67B |
| Gross profit | 13.44%11.8B | 14.93%44.03B | 19.66%10.4B | 4.26%38.31B | 0.98%9.45B | -2.08%10.69B | 20.11%9.48B | 1.34%8.69B | 14.38%36.74B | 11.88%9.35B |
| Operating expense | 1.85%6.4B | 7.93%26.16B | 8.66%6.28B | 1.38%24.24B | -18.31%5.35B | 11.39%6.75B | 12.55%6.36B | 2.30%5.78B | 12.67%23.91B | 17.03%6.55B |
| Operating profit | 31.14%5.4B | 26.99%17.87B | 41.53%4.12B | 9.64%14.07B | 46.02%4.1B | -18.86%3.95B | 39.20%3.12B | -0.51%2.91B | 17.69%12.83B | 1.45%2.81B |
| Net non-operating interest income (expenses) | 41.72%231M | 57.35%996M | 1.24%163M | 102.88%633M | 9.52%115M | 101.23%163M | 203.13%194M | 159.68%161M | 28.40%312M | 45.83%105M |
| Non-operating interest income | 18.53%275M | 60.49%1.25B | 40.61%232M | 122.64%777M | 103.39%240M | 76.14%155M | 197.26%217M | 135.71%165M | 27.84%349M | 53.25%118M |
| Non-operating interest expense | -36.23%44M | 74.31%251M | 1,625.00%69M | 289.19%144M | 861.54%125M | -214.29%-8M | 155.56%23M | -50.00%4M | 23.33%37M | 160.00%13M |
| Net investment income | -73.08%98M | -43.63%513M | -22.06%364M | -51.60%910M | 59.62%-126M | -124.42%-159M | -24.32%728M | -19.34%467M | 420.78%1.88B | -272.38%-312M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 26.97%-130M | -3,075.00%-635M | -178M | 90.65%-20M | -214M | |||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -50.00%5M | -83.93%36M | -28.57%10M | 230.23%224M | 237.50%220M | -350.00%-9M | 90.00%-1M | 14M | 22.52%-172M | 32.20%-160M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --137M | ---- |
| Less:Other special charges | 50.00%-5M | 83.93%-36M | 28.57%-10M | -740.00%-224M | -1,056.52%-220M | 350.00%9M | --1M | ---14M | -84.23%35M | -90.25%23M |
| Other non-operating income (expenses) | -27.03%108M | -12.13%529M | -65.98%148M | 88.13%602M | 101.23%163M | -385.71%-20M | -71.08%24M | 191.95%435M | -23.99%320M | -35.20%81M |
| Income before tax | 23.43%5.71B | 17.59%19.31B | 16.03%4.63B | 9.76%16.42B | 93.06%4.45B | -29.99%3.92B | 21.65%4.06B | 7.32%3.99B | 27.78%14.96B | -20.72%2.3B |
| Income tax | 45.73%1.6B | 26.81%5.34B | 29.87%1.1B | 8.70%4.21B | 58.04%1B | -31.99%944M | 64.88%1.42B | -14.62%847M | 24.33%3.87B | -30.10%634M |
| Net income | 16.48%4.11B | 14.41%13.96B | 12.30%3.53B | 10.12%12.21B | 106.35%3.45B | -29.38%2.97B | 6.69%2.65B | 15.32%3.14B | 29.04%11.08B | -16.50%1.67B |
| Net income continuous operations | 16.48%4.11B | 14.41%13.97B | 12.29%3.53B | 10.13%12.21B | 106.35%3.45B | -29.33%2.98B | 6.65%2.65B | 15.31%3.14B | 29.04%11.08B | -16.46%1.67B |
| Noncontrolling interests | -5.26%18M | 57.14%77M | 11.76%19M | -16.95%49M | 66.67%10M | -53.85%12M | -23.08%10M | 21.43%17M | 68.57%59M | -33.33%6M |
| Net income attributable to the company | 16.63%4.09B | 14.24%13.89B | 12.30%3.51B | 10.28%12.16B | 106.55%3.44B | -29.22%2.96B | 6.85%2.64B | 15.29%3.12B | 28.88%11.02B | -16.42%1.66B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 16.63%4.09B | 14.24%13.89B | 12.30%3.51B | 10.28%12.16B | 106.55%3.44B | -29.22%2.96B | 6.85%2.64B | 15.29%3.12B | 28.88%11.02B | -16.42%1.66B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 9.76%69.71 | 6.96%242.29 | 8.99%63.51 | 10.27%226.53 | 105.30%63.87 | -29.16%55.29 | 7.06%49.1 | 15.59%58.27 | 28.85%205.43 | -16.15%31.11 |
| Diluted earnings per share | 21.63%69.23 | 17.59%237.01 | 13.68%56.92 | 14.26%201.55 | 131.92%61.76 | -29.23%47.53 | 7.11%42.19 | 15.88%50.07 | 29.36%176.39 | -15.94%26.63 |
| Dividend per share | 0 | 28.30%68 | 0 | 15.22%53 | 30.43%30 | 0 | 0.00%23 | 0 | 21.05%46 | 15.00%23 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |